Decoy Therapeutics (DCOY) Other financing activities (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Other financing activities of $429032.0 for Q1 2025, up 2828.75% quarter-over-quarter from $14649.0 in Q2 2021.
Decoy Therapeutics (DCOY) Other financing activities (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Other financing activities for 7 consecutive years, with $429032.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other financing activities changed N/A year-over-year to $429032.0; the TTM figure through Mar 2026 stood at $429032.0 (changed 0.0% YoY), while the FY2025 annual figure was $185032.0, changed N/A from the prior year.
- Other financing activities advanced to $429032.0 in Q1 2025 per DCOY's latest filing, from $14649.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.5 million in Q1 2021 and bottomed at $14649.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 551,799.00 |
| Jun 30, 2026 | 551,799.00 |
| Jun 30, 2025 | -72,048.00 |
| Jun 30, 2025 | -72,048.00 |
| Mar 31, 2025 | 429,032.00 |
| Mar 31, 2025 | 429,032.00 |
| Jun 30, 2021 | 14,649.00 |
| Jun 30, 2021 | 14,649.00 |
| Mar 31, 2021 | 1.49 Mn |
| Mar 31, 2021 | 1.49 Mn |
| Dec 31, 2020 | 3.26 Mn |
| Dec 31, 2020 | 3.26 Mn |
| Sep 30, 2020 | 57,500.00 |
| Sep 30, 2020 | 57,500.00 |
| Jun 30, 2020 | 578,714.00 |
| Jun 30, 2020 | 578,714.00 |
| Jun 30, 2018 | 63,097.00 |
| Jun 30, 2018 | 63,097.00 |
| Mar 31, 2018 | 54,913.00 |
| Mar 31, 2018 | 54,913.00 |